Pages that link to "Q36001198"
Jump to navigation
Jump to search
The following pages link to Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity (Q36001198):
Displaying 16 items.
- Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin. (Q30248439) (← links)
- Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review (Q36246550) (← links)
- Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients (Q37538954) (← links)
- Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium. (Q38677846) (← links)
- Acid-Suppressive Therapy and Risk of Infections: Pros and Cons (Q38865456) (← links)
- Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks (Q38941017) (← links)
- Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain (Q39007494) (← links)
- Duodenal ulcers, gastric ulcers and Helicobacter pylori (Q40349208) (← links)
- Peptic ulcer disease and non-steroidal anti-inflammatory drugs (Q41083345) (← links)
- Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression (Q42371575) (← links)
- Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. (Q52687792) (← links)
- Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. (Q55071130) (← links)
- Peptic ulcer disease (Q55898008) (← links)
- Non-variceal upper gastrointestinal bleeding (Q56379249) (← links)
- Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol (Q91654274) (← links)
- Direct in situ labeling of target drugs with a fluorophore probe to improve MALDI-MS detection sensitivity in micro-liter plasma (Q92186404) (← links)